PMC:7565665 / 1494-1662 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":114,"end":118},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"ted cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeut"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T5","span":{"begin":114,"end":118},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"ted cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeut"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T25","span":{"begin":4,"end":19},"obj":"Disease"},{"id":"T26","span":{"begin":114,"end":126},"obj":"Disease"}],"attributes":[{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0009061"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"}],"text":"ted cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeut"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T10","span":{"begin":4,"end":55},"obj":"http://purl.obolibrary.org/obo/PR_000001044"},{"id":"T11","span":{"begin":57,"end":61},"obj":"http://purl.obolibrary.org/obo/PR_000001044"},{"id":"T12","span":{"begin":114,"end":118},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T13","span":{"begin":114,"end":118},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"ted cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeut"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"26","span":{"begin":4,"end":55},"obj":"Gene"},{"id":"27","span":{"begin":57,"end":61},"obj":"Gene"},{"id":"43","span":{"begin":114,"end":126},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"Gene:1080"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Gene:1080"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D008171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ted cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeut"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":114,"end":126},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002088"}],"text":"ted cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeut"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T19","span":{"begin":4,"end":55},"obj":"http://purl.obolibrary.org/obo/GO_0005260"},{"id":"T20","span":{"begin":57,"end":61},"obj":"http://purl.obolibrary.org/obo/GO_0005260"},{"id":"T21","span":{"begin":63,"end":78},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ted cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeut"}